Pharmacokinetic studies have provided a rationale for enhanced IFN dosing. The initial decline in serum HCV RNA levels seen after a single dose of IFN therapy is believed to reflect a direct antiviral ...
Interferon alfa-2b, recombinant; 10 million, 18 million, or 50 million IU per vial; pwd for inj after reconstitution/dilution; preservative-free; contains albumin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback